Spots Global Cancer Trial Database for human epidermal growth factor receptor 3
Every month we try and update this database with for human epidermal growth factor receptor 3 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase I Study of U3P1287/01, Including Patients With Advanced Solid Tumors | NCT00730470 | Advanced Solid ... | U3-1287 (AMG888... | 18 Years - | U3 Pharma GmbH | |
Phase I Study of U3P1287/01, Including Patients With Advanced Solid Tumors | NCT00730470 | Advanced Solid ... | U3-1287 (AMG888... | 18 Years - | U3 Pharma GmbH |